Child pages
  • Imaging characterization of a metastatic patient derived model of adenocarcinoma pancreas: (PDMR-292921-168-R)

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...


Excerpt

Pre-clinical animal models of spontaneous metastatic cancer are infrequent; the few that exist are resource intensive because determination of the presence of metastatic disease, metastatic burden, and response to therapy normally require multiple timed cohorts with animal sacrifice and extensive pathological examination. We identified and characterized a patient derived xenograft model with metastatic potential, adenocarcinoma pancreas xenograft 292921-168-R. In this study we performed a detailed imaging characterization (workflow below) of this model, which develops spontaneous lung metastases, details are provided in the attached standard operating procedures. Tumors in half of the mice were resected in the range 200-300 cm3 size; tumors in the other half were allowed to grow until it was necessary to euthanize them because of tumor size.

Image Modified

The imaging characteristics of this model (PDMR-292921-168-R), which is available from the National Cancer Institute Patient-Derived Models Repository (https://pdmr.cancer.gov/), is highly favorable for preclinical research studies of metastatic disease when used in conjunction with non-contrast T2 weighted MRI.

Results: Adenocarcinoma pancreas (PDMR-292921-168-R)

...

Table 1: Penetrance and location of pathological confirmed metastatic lesion(s).

# animals in Group

# animals that displayed metastasis in MRI and confirmed by Pathology

Pathology confirmation of MRI (primary imaging site)

Other confirmed Location (s)

10 (non-resected)

4   

(5 mice were EU due to xenograft size prior to observation of metastases)

Lung

Lung

10 (resected)

10

Lung

Lung, Kidney, Nodes, Peritoneal Wall

...

Percent penetrance with respect to the average time-to-metastasis for non-resected (plot A: time from implant) and resected (plot B: time from tumor resection) cohorts.

Image Removed

Image Added

Plot A

Image Removed

Image Added

Plot B

PET/CT Characterization of the primary tumor:  Baseline PET (SOP available below) were performed when tumor reached an approximate 200 mm3.   Average SUVmax values (n=5) were calculated; [18F]FDG: 1.3 ± 0.2 and [18F]FLT: 2.3 ± 0.6.

Conclusion

Excellent metastatic model with at least 50% penetrance un-resected and 100% with planned early resection.  Metastases are well observed on T2 MRI imaging allowing non-invasive evaluation in treatment trials.

...